Severe asthma registry study in Hong Kong
Part of Immune system & allergy, Lungs & breathing clinical trials.
This study collects health information from adults with severe asthma to better understand the condition and improve treatment. Your participation involves sharing medical data to help researchers learn more about what works best for severe asthma.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years old or older
- You have been diagnosed with severe asthma
- You are able to provide written consent (sign paperwork agreeing to participate)
- You can communicate in a language the study team understands
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at how biologic medicines (special injections or infusions) are used to treat severe asthma in Hong Kong. It may help researchers understand why some people stop or switch these treatments.
This study looks at people with severe asthma who also have other health conditions. It aims to understand how these conditions affect asthma and its treatment.
This study looks at how asthma affects people in China and tries to find patterns that might help predict which treatments work best. If you have asthma and are between 18 and 75, you may be able to join.
This study enrolls people in specific cities to collect health information that helps researchers better understand asthma and how to recruit future studies. It may help by improving knowledge about asthma types and care in real-world settings.
This study is creating a registry to track the long-term safety and effectiveness of biologic treatments for severe asthma in Taiwan. If you are taking a biologic like omalizumab, mepolizumab, or benralizumab, joining this registry helps doctors learn how well these medicines work over time.
This study follows adults with asthma in real life to better understand asthma care and outcomes. You may be invited if you already joined another asthma-related or health-related observational study and don’t have certain major lung or health conditions.
Hear when a new Asthma trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.